Verified· 3 sources

Veraxa Biotech AG

Summary

About the company

Veraxa Biotech Holding AG develops antibody-based cancer therapeutics, including antibody–drug conjugates (ADCs) and BiTAC bispecific formats, and employs proprietary technologies such as droplet‑based functional antibody screening, genetic code expansion for positional conjugation, and bioorthogonal click chemistry. The company is advancing a proprietary oncology pipeline that includes ADC and BiTAC TCE programs, with the VX‑A901 program in clinical studies for AML.

AI-generated

Offering

Products & services

Industry:Holding Companies

✓ Offered6

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Veraxa Biotech AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Veraxa Biotech AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Media

No knowledge articles yet

Veraxa Biotech AG in comparison

Industry comparisons are coming soon

Similar companies